Radiotherapy, chemotherapy, targeted therapy, and possibly immunotherapy in localised sarcoma

As clinicians have gained an improved understanding of the biology of soft-tissue sarcoma (STS) malignancies, the ability to better distinguish and identify STS subtypes has extended the hope that exploiting the molecular characteristics of each subtype will lead to the emergence of targeted treatment options.
Targeted Oncology